Small airways in progressive systemic sclerosis (PSS). 1979

R D Bjerke, and D P Tashkin, and P J Clements, and S K Chopra, and H Gong, and M Bein

Obstructive disease involving peripheral airways has been noted in diffuse interstitial pulmonary disease, including sarcoidosis and cryptogenic fibrosing alveolitis. The possibility of obstruction of small airways in progressive systemic sclerosis (PSS) has been suggested by widespread bronchiolectasis and peribronchial fibrosis noted at necropsy. We performed pulmonary function studies in 39 subjects (22 nonsmokers and 17 smokers) with PSS, most of whom had functional evidence of interstitial pulmonary involvement (increased static recoil pressure and reduced diffusing capacity). The 1 second forced expiratory volume to forced vital capacity ratio (FEV1:FVC) was normal in all subjects. Although the severity of the restrictive process was greater in nonsmokers compared with that in smokers, the maximal mid-expiratory flow rate, closing volume, closing capacity, volume of isoflow, change in maximal expiratory flow at 50 per cent of vital capacity during 80 per cent helium--20 per cent oxygen breathing compared with air breathing (delta Vmax50), ratio of dynamic to static lung compliance at different breathing frequencies and upstream airway conductance at static recoil pressures of 5 and 10 cm H2O were nearly always normal in the nonsmokers but were frequently abnormal in the smokers with PSS. These findings suggest that diffuse interstitial pulmonary disease due to PSS generally does not lead to functional evidence of obstruction in peripheral airways and that when the latter is found it can likely be attributed to the effects of concomitant cigarette smoking.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000403 Airway Resistance Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow. Airway Resistances,Resistance, Airway,Resistances, Airway
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

R D Bjerke, and D P Tashkin, and P J Clements, and S K Chopra, and H Gong, and M Bein
January 1987, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology,
R D Bjerke, and D P Tashkin, and P J Clements, and S K Chopra, and H Gong, and M Bein
January 1981, Bollettino della Societa italiana di cardiologia,
R D Bjerke, and D P Tashkin, and P J Clements, and S K Chopra, and H Gong, and M Bein
August 1982, Ryumachi. [Rheumatism],
R D Bjerke, and D P Tashkin, and P J Clements, and S K Chopra, and H Gong, and M Bein
February 1982, Seminars in arthritis and rheumatism,
R D Bjerke, and D P Tashkin, and P J Clements, and S K Chopra, and H Gong, and M Bein
June 1982, The Journal of the Association of Physicians of India,
R D Bjerke, and D P Tashkin, and P J Clements, and S K Chopra, and H Gong, and M Bein
January 1987, Clinical and experimental rheumatology,
R D Bjerke, and D P Tashkin, and P J Clements, and S K Chopra, and H Gong, and M Bein
October 1982, Journal of clinical immunology,
R D Bjerke, and D P Tashkin, and P J Clements, and S K Chopra, and H Gong, and M Bein
January 1983, Clinical and experimental rheumatology,
R D Bjerke, and D P Tashkin, and P J Clements, and S K Chopra, and H Gong, and M Bein
January 1973, Bibliotheca anatomica,
R D Bjerke, and D P Tashkin, and P J Clements, and S K Chopra, and H Gong, and M Bein
January 1984, Acta dermato-venereologica,
Copied contents to your clipboard!